Related Experiment Video

Updated: Jun 21, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma

James A Bonner1, Hoa Q Trummell, Christopher D Willey

  • 1Department of Radiation Oncology, The University of Alabama at Birmingham, AL 35233, USA. gesims@uabmc.edu

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|July 21, 2009
PubMed
Abstract

Insights

Inhibiting Signal Transducer and Activator of Transcription-3 (STAT-3) in cancer cells enhances their sensitivity to radiation therapy. This study demonstrates STAT-3 knockdown via shRNA leads to radiosensitization in A431 cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Signal transducer and activator of transcription-3 (STAT-3) is implicated in tumor resistance to cancer treatments.
  • STAT-3 is a downstream mediator of Epidermal Growth Factor Receptor (EGFr) signaling.
  • Investigating STAT-3 inhibition for cancer treatment strategies.

Purpose of the Study:

  • To determine if inhibiting STAT-3 can radiosensitize tumor cells.
  • To evaluate the efficacy of STAT-3 knockdown in enhancing radiation sensitivity.

Main Methods:

  • A431 human squamous cell carcinoma cells with overexpressed EGFr were used.
  • STAT-3 was inhibited using small interfering RNA (siRNA) and short hairpin RNA (shRNA).
  • Stable STAT-3 knockdown was achieved using shRNA cloned into a pBABE vector, with clone 2.1 selected for study.

Main Results:

  • STAT-3 small interfering RNA (siRNA) sensitized A431 cells to radiation.
  • Stable shRNA-mediated STAT-3 knockdown significantly reduced STAT-3 protein and mRNA levels.
  • A431 cells with STAT-3 knockdown exhibited increased sensitivity to radiation compared to controls.

Conclusions:

  • Stable transfection of A431 cells with shRNA targeting STAT-3 resulted in enhanced radiosensitivity.
  • Further research is needed to confirm if STAT-3 phosphorylation inhibition is crucial for EGFr-induced radiosensitization.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...